Have You Seen BioPharm International's New and Improved Site Design?
» Visit www.biopharminternational.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.

BioPharm International is pleased to present its 2010 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand.

Featured Webcasts:

BIOPHARM INTERNATIONAL 2010 WEBCAST SERIES
BioPharm International is pleased to present its 2010 Web Seminar Series, addressing key issues in process development and bioprocessing. These one-hour sessions include presentations by industry experts and interactive dialogue with the audience. Watch live and participate in the Q&A, or catch them later on demand.

Tuesday, June 22, 2010 2:00 PM ET
SGS Webcast Series Part 2: What's New in Pharmaceutical Laboratory Testing Requirements? Focus on: Extractables and Leachables
Monomers and additives such as antioxidants, plasticizers, and stabilizers may potentially migrate into medicinal products and should be evaluated as required by regulatory authorities. Processing equipment as well as primary and secondary container materials must be considered. This webinar will highlight the changes affecting industry in the area of extractables and leachables testing, including a look at implementing ICH Q4B and global pharmacopeial differences between USP, JP, and Ph.Eur. requirements.

Wednesday, June 23, 2010 11:00 AM ET
What Early Stage Companies Need to Know About Quality Management: Lessons Learned from Industry Leaders
What Early Stage Companies Need to Know About Quality Management: Lessons Learned from Industry Leaders Live Event Date/Time: June 23, 2010 at 11:00 AM EDT Life sciences companies are trying to cope with the mounting challenges of managing and maintaining quality systems while facing increased compliance risks. Clinical trials are becoming more complex and the FDA is scrutinizing data to a higher degree. This is leading to increased demands on quality organizations, and many are drowning in paper-based systems while struggling to maintain compliance. A panel of industry professionals will share, through a facilitated discussion, their experiences with deploying and realizing the benefits of QMS. They will discuss best practices they have implemented and lessons they have learned.

Tuesday, June 29, 2010 2:00 PM ET
SGS Webcast Series Part 3: What's New in Pharmaceutical Laboratory Testing Requirements? Focus on: Melamine and Contamination Challenges
This webinar will highlight the changes affecting industry in the area of melamine testing and related contamination issues, including recent FDA guidance, USP monographs, and international harmonization efforts.

Analytical Strategies for Monitoring Residual Impurities Encountered In Bioprocessing
Profiling of impurities in biopharmaceuticals and their associated intermediates and excipients is a regulatory expectation. Since residuals are typically present at low levels in difficult sample matrices, development and validation of assays can be quite challenging. Due to the range of potential impurities, many different analytical strategies are needed.

In-Vivo Spectroscopy: Studies of Skin and Cartilage
Non-ivasive FTIR is used to study skin chemistry and identify diseased cartilage tissue.

Efficient Development of Peptide Maps using the ACQUITY UPLC H-Class System
The ACQUITY UPLC H-Class System is used for the systematic optimization of peptide mapping conditions in a fully automated protocol using four-solvent blending. The system's four-solvent blending capability enables the user to focus on the quality of the analysis so that reliable results can be obtained efficiently.